Cargando…

Does Naloxone Reinstate Secondary Hyperalgesia in Humans after Resolution of a Burn Injury? A Placebo-Controlled, Double-Blind, Randomized, Cross-Over Study

INTRODUCTION: Development of secondary hyperalgesia following a cutaneous injury is a centrally mediated, robust phenomenon. The pathophysiological role of endogenous opioid signalling to the development of hyperalgesia is unclear. Recent animal studies, carried out after the resolution of inflammat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Manuel P., Werner, Mads U., Ringsted, Thomas K., Rowbotham, Michael C., Taylor, Bradley K., Dahl, Joergen B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669421/
https://www.ncbi.nlm.nih.gov/pubmed/23741350
http://dx.doi.org/10.1371/journal.pone.0064608
_version_ 1782271754393092096
author Pereira, Manuel P.
Werner, Mads U.
Ringsted, Thomas K.
Rowbotham, Michael C.
Taylor, Bradley K.
Dahl, Joergen B.
author_facet Pereira, Manuel P.
Werner, Mads U.
Ringsted, Thomas K.
Rowbotham, Michael C.
Taylor, Bradley K.
Dahl, Joergen B.
author_sort Pereira, Manuel P.
collection PubMed
description INTRODUCTION: Development of secondary hyperalgesia following a cutaneous injury is a centrally mediated, robust phenomenon. The pathophysiological role of endogenous opioid signalling to the development of hyperalgesia is unclear. Recent animal studies, carried out after the resolution of inflammatory pain, have demonstrated reinstatement of tactile hypersensitivity following administration of μ-opioid-receptor-antagonists. In the present study in humans, we analyzed the effect of naloxone when given after the resolution of secondary hyperalgesia following a first-degree burn injury. METHODS: Twenty-two healthy volunteers were included in this placebo-controlled, randomized, double-blind, cross-over study. Following baseline assessment of thermal and mechanical thresholds, a first-degree burn injury (BI; 47°C, 7 minutes, thermode area 12.5 cm(2)) was induced on the lower leg. Secondary hyperalgesia areas around the BI-area, and separately produced by brief thermal sensitization on the contralateral thigh (BTS; 45°C, 3 minutes, area 12.5 cm(2)), were assessed using a polyamide monofilament at pre-BI and 1, 2, and 3 hours post-BI. At 72 hrs, BI and BTS secondary hyperalgesia areas were assessed prior to start of a 30 minutes intravenous infusion of naloxone (total dose 21 microg/kg) or placebo. Fifteen minutes after start of the infusion, BI and BTS secondary hyperalgesia areas were reassessed, along with mechanical and thermal thresholds. RESULTS: Secondary hyperalgesia areas were demonstrable in all volunteers 1–3 hrs post-BI, but were not demonstrable at 72 hrs post-burn in 73–86% of the subjects. Neither magnitude of secondary hyperalgesia areas nor the mechanical and thermal thresholds were associated with naloxone-treated compared to placebo-treated subjects. CONCLUSION: Naloxone (21 microg/kg) did not reinstate secondary hyperalgesia when administered 72 hours after a first-degree burn injury and did not increase BTS-generated hyperalgesia. The negative results may be due to the low dose of naloxone or insufficient tissue injury to generate latent sensitization.
format Online
Article
Text
id pubmed-3669421
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36694212013-06-05 Does Naloxone Reinstate Secondary Hyperalgesia in Humans after Resolution of a Burn Injury? A Placebo-Controlled, Double-Blind, Randomized, Cross-Over Study Pereira, Manuel P. Werner, Mads U. Ringsted, Thomas K. Rowbotham, Michael C. Taylor, Bradley K. Dahl, Joergen B. PLoS One Research Article INTRODUCTION: Development of secondary hyperalgesia following a cutaneous injury is a centrally mediated, robust phenomenon. The pathophysiological role of endogenous opioid signalling to the development of hyperalgesia is unclear. Recent animal studies, carried out after the resolution of inflammatory pain, have demonstrated reinstatement of tactile hypersensitivity following administration of μ-opioid-receptor-antagonists. In the present study in humans, we analyzed the effect of naloxone when given after the resolution of secondary hyperalgesia following a first-degree burn injury. METHODS: Twenty-two healthy volunteers were included in this placebo-controlled, randomized, double-blind, cross-over study. Following baseline assessment of thermal and mechanical thresholds, a first-degree burn injury (BI; 47°C, 7 minutes, thermode area 12.5 cm(2)) was induced on the lower leg. Secondary hyperalgesia areas around the BI-area, and separately produced by brief thermal sensitization on the contralateral thigh (BTS; 45°C, 3 minutes, area 12.5 cm(2)), were assessed using a polyamide monofilament at pre-BI and 1, 2, and 3 hours post-BI. At 72 hrs, BI and BTS secondary hyperalgesia areas were assessed prior to start of a 30 minutes intravenous infusion of naloxone (total dose 21 microg/kg) or placebo. Fifteen minutes after start of the infusion, BI and BTS secondary hyperalgesia areas were reassessed, along with mechanical and thermal thresholds. RESULTS: Secondary hyperalgesia areas were demonstrable in all volunteers 1–3 hrs post-BI, but were not demonstrable at 72 hrs post-burn in 73–86% of the subjects. Neither magnitude of secondary hyperalgesia areas nor the mechanical and thermal thresholds were associated with naloxone-treated compared to placebo-treated subjects. CONCLUSION: Naloxone (21 microg/kg) did not reinstate secondary hyperalgesia when administered 72 hours after a first-degree burn injury and did not increase BTS-generated hyperalgesia. The negative results may be due to the low dose of naloxone or insufficient tissue injury to generate latent sensitization. Public Library of Science 2013-05-31 /pmc/articles/PMC3669421/ /pubmed/23741350 http://dx.doi.org/10.1371/journal.pone.0064608 Text en © 2013 Pereira et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Pereira, Manuel P.
Werner, Mads U.
Ringsted, Thomas K.
Rowbotham, Michael C.
Taylor, Bradley K.
Dahl, Joergen B.
Does Naloxone Reinstate Secondary Hyperalgesia in Humans after Resolution of a Burn Injury? A Placebo-Controlled, Double-Blind, Randomized, Cross-Over Study
title Does Naloxone Reinstate Secondary Hyperalgesia in Humans after Resolution of a Burn Injury? A Placebo-Controlled, Double-Blind, Randomized, Cross-Over Study
title_full Does Naloxone Reinstate Secondary Hyperalgesia in Humans after Resolution of a Burn Injury? A Placebo-Controlled, Double-Blind, Randomized, Cross-Over Study
title_fullStr Does Naloxone Reinstate Secondary Hyperalgesia in Humans after Resolution of a Burn Injury? A Placebo-Controlled, Double-Blind, Randomized, Cross-Over Study
title_full_unstemmed Does Naloxone Reinstate Secondary Hyperalgesia in Humans after Resolution of a Burn Injury? A Placebo-Controlled, Double-Blind, Randomized, Cross-Over Study
title_short Does Naloxone Reinstate Secondary Hyperalgesia in Humans after Resolution of a Burn Injury? A Placebo-Controlled, Double-Blind, Randomized, Cross-Over Study
title_sort does naloxone reinstate secondary hyperalgesia in humans after resolution of a burn injury? a placebo-controlled, double-blind, randomized, cross-over study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669421/
https://www.ncbi.nlm.nih.gov/pubmed/23741350
http://dx.doi.org/10.1371/journal.pone.0064608
work_keys_str_mv AT pereiramanuelp doesnaloxonereinstatesecondaryhyperalgesiainhumansafterresolutionofaburninjuryaplacebocontrolleddoubleblindrandomizedcrossoverstudy
AT wernermadsu doesnaloxonereinstatesecondaryhyperalgesiainhumansafterresolutionofaburninjuryaplacebocontrolleddoubleblindrandomizedcrossoverstudy
AT ringstedthomask doesnaloxonereinstatesecondaryhyperalgesiainhumansafterresolutionofaburninjuryaplacebocontrolleddoubleblindrandomizedcrossoverstudy
AT rowbothammichaelc doesnaloxonereinstatesecondaryhyperalgesiainhumansafterresolutionofaburninjuryaplacebocontrolleddoubleblindrandomizedcrossoverstudy
AT taylorbradleyk doesnaloxonereinstatesecondaryhyperalgesiainhumansafterresolutionofaburninjuryaplacebocontrolleddoubleblindrandomizedcrossoverstudy
AT dahljoergenb doesnaloxonereinstatesecondaryhyperalgesiainhumansafterresolutionofaburninjuryaplacebocontrolleddoubleblindrandomizedcrossoverstudy